Where Does Kalvista Pharmaceuticals Inc (KALV) Stock Fall in the Biotechnology Field After It Is Lower By -1.04% This Week?

Kalvista Pharmaceuticals Inc (KALV) is around the top of the Biotechnology industry according to InvestorsObserver. KALV received an overall rating of 66, which means that it scores higher than 66 percent of all stocks. Kalvista Pharmaceuticals Inc also achieved a score of 85 in the Biotechnology industry, putting it above 85 percent of Biotechnology stocks. Biotechnology is ranked 53 out of the 148 industries.

KALV has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on KALV!

See Full KALV Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 66 would rank higher than 66 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Kalvista Pharmaceuticals Inc Stock Today?

Kalvista Pharmaceuticals Inc (KALV) stock has fallen -1.62% while the S&P 500 is higher by 0.46% as of 11:52 AM on Wednesday, Nov 22. KALV is down -$0.12 from the previous closing price of $7.73 on volume of 45,839 shares. Over the past year the S&P 500 is higher by 13.87% while KALV is higher by 44.68%. KALV lost -$3.16 per share the over the last 12 months. Click Here to get the full Stock Report for Kalvista Pharmaceuticals Inc stock.